Becton, Dickinson and Company

BDX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009 FY2008 FY2007
Operating Activities
Net Income $1.23B $1.13B $890.0M
Depreciation & Amortization $464.6M $472.0M $441.1M
Depreciation $312.3M $300.4M —
Amortization $47.1M $54.2M —
Stock-Based Compensation $86.6M $100.6M $107.7M
Net Cash from Operating Activities $1.66B $1.62B $1.23B
Investing Activities
Capital Expenditures $585.2M $595.8M $556.3M
Business Acquisitions $0 $41.3M $339.5M
Net Cash from Investing Activities — — —
Financing Activities
Dividends Paid $316.9M $278.5M $239.8M
Stock Repurchases $550.0M $450.0M $450.1M
Net Cash from Financing Activities — — —
Net Change in Cash $563.8M $319.0M $-488.8M
Free Cash Flow $1.07B $1.02B $673.7M
← Newer Page 3 of 3 Older →